[1]
“Clinical Response and Toxicities of Neo-Adjuvant Concurrent Chemoradiation with Tablet Capecitabine or Mayo-Clinic Regimen in locally advanced Rectal Cancer: A Comparative Study”, acbr, vol. 6, no. 6, pp. 944–953, Nov. 2022, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/acbr/article/view/14975